key: cord-0727429-050cyluf authors: Hokama, Larissa Tami; Veiga, Alicia Dudy Müller; Menezes, Maria Clara Saad; Sardinha Pinto, Agnes Araujo; de Lima, Thais Martins; Ariga, Suely Kunimi Kubo; Barbeiro, Hermes Vieira; Barbeiro, Denise Frediani; de Lucena Moreira, Claudia; Stanzani, Gabriela; Brandao, Rodrigo Antonio; Marchini, Julio Flavio; Alencar, Julio Cesar; Marino, Lucas Oliveira; Gomez, Luz Marina; Souza, Heraldo P. title: Endothelial injury in COVID-19 and septic patients date: 2021-12-13 journal: Microvasc Res DOI: 10.1016/j.mvr.2021.104303 sha: 5cc09067a1b297382d01c879e49e1117331f48e3 doc_id: 727429 cord_uid: 050cyluf Systemic inflammatory response, as observed in sepsis and severe COVID-19, may lead to endothelial damage. Therefore, we aim to compare the extent of endothelial injury and its relationship to inflammation in both diseases. We included patients diagnosed with sepsis (SEPSIS group, n = 21), mild COVID-19 (MILD group, n = 31), and severe COVID-19 (SEVERE group, n = 24). Clinical and routine laboratory data were obtained, circulating cytokines (INF-γ, TNF-α, and IL-10) and endothelial injury markers (E-Selectin, Tissue Factor (TF) and von Willebrand factor (vWF)) were measured. Compared to the SEPSIS group, patients with severe COVID-19 present similar clinical and laboratory data, except for lower circulating IL-10 and E-Selectin levels. Compared to the MILD group, patients in the SEVERE group showed higher levels of TNF-α, IL-10, and TF. There was no clear relationship between cytokines and endothelial injury markers among the three studied groups; however, in SEVERE COVID-19 patients, there is a positive relationship between INF-γ with TF and a negative relationship between IL-10 and vWF. In conclusion, COVID-19 and septic patients have a similar pattern of cytokines and endothelial dysfunction markers. These findings highlight the importance of endothelium dysfunction in COVID-19 and suggest that endothelium should be better evaluated as a therapeutic target for the disease. Since the early descriptions of COVID-19 (1) , it became clear that the disease could affect the vasculature (2) . Patients who developed severe forms of the disease present with thrombotic phenomena (3) and systemic inflammation (4) , suggesting the participation of the endothelium in the disease pathogenesis (2) . Moreover, increased endothelial injury markers have been found in COVID-19 patients and are correlated to the disease severity (5) . Later, this hypothesis was confirmed when data from autopsies showed the presence of viral elements within the endothelial cell, leading to apoptosis and infiltration of inflammatory cells, characterizing diffuse endothelitis (6) . Thus, these findings in deceased patients could suggest previous endothelial activation during COVID-19 evolution. The vascular endothelium is responsible for maintaining the homeostasis in the organism. It controls vascular relaxation and constriction, participates in fibrinolysis and coagulation, and it is also essential to regulate immune responses (7) . Under pathological conditions, endothelial cells assume an activated state, leading to a proinflammatory and procoagulant state (8) . As observed in sepsis and COVID-19, systemic inflammation is one of the most potent inductors of endothelial activation (9) . Both diseases, in their more severe forms, present with a high mortality rate (10, 11) and are characterized by intense activation of immune mediators ("cytokine storm") (4,12) and prothrombotic and antifibrinolytic state (13) . However, the extension of endothelial activation and its relationship with mortality is unclear, both in sepsis and COVID-19. Moreover, doubts persist about the causative effect of endothelial dysfunction in COVID-19. In this study, we aim to determine the presence of circulating markers of endothelial dysfunction (E-selectin, Tissue Factor (TF) and von Willebrand factor (vWF)) (14) and cytokines in patients with COVID-19 or sepsis. We show here that both diseases present with endothelial injury related to the degree of inflammation. This is a retrospective cohort study, with patients enrolled at the Emergency Department of the Hospital das da Faculdade de Medicina da Universidade de São Paulo, São Paulo, Brazil. It is a tertiary hospital designated to assist only patients with severe acute respiratory syndromes (SARS) during the COVID-19 pandemic. The protocol was approved by the institutional Ethics Committee, under number CAAE: 30417520.0.0000.0068. All patients, or their legal representatives, signed the informed consent. We enrolled consecutive patients admitted to the Emergency Department with a diagnosis of severe COVID-19 or sepsis. COVID-19 was diagnosed by a positive SARS-CoV-2 RT-PCR test in nasopharyngeal and throat swabs and by typical chest CT-scan findings. All enrolled patients had hypoxemia (as defined by peripheral oxygen saturation less than 92 %) and were using supplemental oxygen. All of them were classified as severe cases by WHO guidelines (15) . Sepsis was diagnosed using the Sepsis-3 criteria (16) . We selected only patients who died from sepsis to compare with the patients who died from COVID-19. All of the septic patients had a negative result for the SARS-Cov-2 RT-PCR test. Patients under 18 years old, pregnant women, and patients in end-of-life protocols were not included. All patients were evaluated and treated according to the Institution's protocol. After emergency department assessment, they were transferred to hospital yards or intensive care units according to each severe state. On the first day of hospitalization, patients were submitted to chest tomography, routine laboratory tests, and an additional 20-ml blood sample was collected in a tube J o u r n a l P r e -p r o o f with trisodium citrate that was immediately sent to the laboratory. The whole blood was separated by centrifugation, and small aliquots of leukocytes and plasma were stored at -80oC until the measurements. Clinical, radiological, and routine laboratory tests were obtained from electronic medical records. Continuous variables were submitted to the Shapiro-Wilkins test for normality. When distribution was normal, Student's t-test was used to compare the means, and results were presented as mean± standard error of the mean (SEM). The Kruskal Wallis test with Dunn's correction was used when data were not normally distributed and presented as median and interquartile range. For categorical variables, the chi-square test was performed. We initially compared patients who died from SEVERE COVID-19 or sepsis. There was no difference between the septic and COVID-19 patients regarding age, previous diseases, and laboratory markers (Table 1) . We further evaluated the endothelial dysfunction markers in COVID-19 patients classified as mildly or severely ill. Initially, we observed that both groups were very similar in demographic and clinical variables. There was no difference in age or previous diseases, although a higher serum level of creatinine and C-reactive protein (CRP) were found in the SEVERE group, compared to MILD. Notwithstanding, except for renal function and the low-grade systematic inflammation marker, no other laboratory test differs between the experimental groups. (Table 2) Higher levels of TNF-α and IL-10 were detected in patients in the SEVERE group, compared to the MILD one, but there was no difference in serum level of INF-γ. ( Figure 3 ). Circulating TF was also higher in the severely ill patients, while the other endothelial dysfunction markers (vWF and E-Selectin) did not differ between groups ( Figure 4) . To better understand the mechanisms of endothelial injury, we sought the relationship between inflammatory and endothelial injury markers. As observed in Table 3 , there was no clear relationship between cytokines and endothelial injury markers among the three studied groups. Nevertheless, some important correlations were found. Particularly intriguing are the positive relationship between INF-γ with TF in SEVERE COVID-19 patients and the negative relationship between IL-10 and vWF in this same group of patients. This study shows that COVID-19 and septic patients present a similar profile of inflammatory and endothelial dysfunction markers. Initially, we compared the inflammatory reaction in septic and COVID-19 patients. There was no difference in circulating white blood cell counts, CRP, and cytokines between these two groups of patients. The only exception was decreased levels of IL-10 in COVID-19 patients. IL-10 is a cytokine mainly produced by activated TH2 lymphocytes, monocytes, and epithelial cells. It suppresses the interferon synthesis and other TH1 cytokines, such as IL-12 and IL-18; therefore, it is considered an anti-inflammatory cytokine (17) . IL-10 plasma levels are elevated in septic patients and correlate with proinflammatory cytokine levels (like TNF-α) and unfavorable outcomes (18) . Interestingly, high plasma IL-10 levels have also been reported in COVID-19 patients. In a review that evaluated 27 studies comprising 3,939 COVID-19 patients in China, high IL-10 levels were reported in almost half of them (19) . Here we report that IL-10 levels are higher in septic patients than in COVID-19 patients. This finding suggests that bacterial infection may lead to a more consistent anti-inflammatory response. However, since we included only patients who died, it is not possible to evaluate the IL-10 role as a modulator of inflammation in these diseases. We further analyzed the endothelial injury markers in septic and COVID-19 patients. E-Selectin is a cell adhesion molecule expressed by endothelial cells activated by cytokines. It has an essential role in recruiting leukocytes to the inflammation site, helping to eliminate the potential invading pathogens (20) . E-Selectin blood levels rise early during sepsis, and it is suggested to be used as a severity marker for the disease (21) . High circulating E-Selectin levels have also been reported in COVID-19 patients and are correlated with the disease severity (22) . In this study, we detected higher E-selectin levels in septic patients compared to COVID-19 patients. A possible explanation for this finding is the necessity to J o u r n a l P r e -p r o o f phagocytize the invading pathogens in septic patients, leading to a more robust chemoattractant response. Our next step was to compare the mildly and severely ill COVID-19 patients. Firstly, a higher level of CRP in SEVERE COVID-19 patients compared to the MILD group can be observed. CRP is a sensitive marker for low-grade systematic inflammation, and it is associated with a higher risk of developing ischemic stroke, peripheral arterial disease, myocardial infarction, and coronary heart disease (23). The higher levels in the SEVERE group indicate that these patients have a basal low-grade systematic inflammation, which cannot be observed in the MILD patients. Furthermore, we found higher TNF-α, IL-10, and TF levels in severely ill COVID-19 patients, compared to the MILD group. This is an interesting finding, and it is in accordance with other authors (24) ; however, this issue is not consensual and more research should be performed to better understand this signaling pathway. TF is a protein expressed in the subendothelial tissue and, together with factor VIIa, is responsible for activating the extrinsic pathway of coagulation (25) . TF expression has been reported to be enhanced by inflammatory cytokines, and TF has been reported to be overexpressed in septic patients (26) . TF has also been found in high levels in COVID-19 patients (24) . This finding may, in part, explain the high incidence of thrombotic phenomena in COVID-19 patients (27) . Although we could observe increased levels of inflammatory and endothelial injury markers in septic and COVID-19 patients, there was no clear relationship between them. Nevertheless, some interesting findings need to be discussed. First, there was a positive and significant relationship between INF-γ and TF in severe COVID-19 patients. This finding may suggest that interferon secretion initiated by the antiviral response may also trigger the thrombotic events observed in these patients. Second, in this same group of patients, there was a negative relationship between IL-10 and vWF, suggesting A pneumonia outbreak associated with a new coronavirus of probable bat origin COVID-19 Vasculopathy: Mounting Evidence for an Indirect Mechanism of Endothelial Injury COVID-19-associated coagulopathy, and antithrombotic agents-lessons after one year An inflammatory cytokine signature predicts COVID-19 severity and survival Biomarkers of endothelial dysfunction and outcomes in coronavirus disease 2019 (COVID-19) patients: A systematic review and meta-analysis Endothelial cell infection and endotheliitis in COVID-19 Vascular Endothelial Cell Biology: An Update Assessment and treatment of endothelial dysfunction in humans Evolving functions of endothelial cells in inflammation Time to Treatment and Mortality during Mandated Emergency Care for Sepsis Characterisation of the first 250 000 hospital admissions for COVID-19 in Brazil: a retrospective analysis of nationwide data The immunopathology of sepsis and potential therapeutic targets The Endothelium in Sepsis Endothelial dysfunction in diabetes: potential application of circulating markers as advanced diagnostic and prognostic tools Clinical Management of Covid-19-Interim Guidance The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) Interleukin-10 Clinical and biological significance of interleukin-10 plasma levels in patients with septic shock Cytokine storm and leukocyte changes in mild versus severe SARS-CoV-2 infection: Review of 3939 COVID-19 patients in China and emerging pathogenesis and therapy concepts E-selectin, and intercellular adhesion molecule-1 are released by activated human endothelial cells in vitro Endothelial dysfunction is an early indicator of sepsis and neutrophil degranulation of septic shock in surgical patients Angiopoietin-2 as a marker of endothelial activation is a good predictor factor for intensive care unit admission of COVID-19 patients Prospective study of Creactive protein and the risk of future cardiovascular events among apparently healthy women Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality-Brief Report Regulation of the tissue factor gene Role of Antithrombin III and Tissue Factor Pathway in the Pathogenesis of Sepsis incidence of thrombotic complications in critically ill ICU patients with COVID-19